Medicine
Lamivudine and Zidovudine 150 mg/300 mg tablet
Lamivudine and Zidovudine 150 mg/300 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Lamivudine and Zidovudine
- Brand
- Sold under the generic name
- Strength
- 150 mg/300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 500 tablets, 60 tablets, 100 tablets and 15 more
- Manufacturers
- Camber PharmaceuticalsIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaBryant Ranch PrepackExelan PharmaceuticalsPD-Rx PharmaceuticalsXLCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AR01 Lamivudine and Zidovudine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 February 2014
- Identifiers
- RxCUI 200082DailyMed set ID d40292ff-046c-4a04-b801-10768667951a, 55520835-0f24-4e52-af8c-d65841ccaba7, ff62c5fc-965d-4534-a571-a4f290cb9d83 +6NDC 65862-036, 72865-144, 43063-900 +6Application ANDA077558, ANDA203259, ANDA079124 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 tablet, film coated in 1 bottle | 31722-506-05 | Camber PharmaceuticalsIndia | 18 September 2015 |
| 60 tablet, film coated in 1 bottle | 31722-506-60 | Camber PharmaceuticalsIndia | 18 September 2015 |
| 500 tablet, film coated in 1 bottle | 31722-739-05 | Camber PharmaceuticalsIndia | 6 February 2014 |
| 100 tablet, film coated in 1 blister pack | 31722-739-31 | Camber PharmaceuticalsIndia | 6 February 2014 |
| 60 tablet, film coated in 1 bottle | 31722-739-60 | Camber PharmaceuticalsIndia | 6 February 2014 |
| 6 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-036-10 | Aurobindo PharmaIndia | 5 May 2017 |
| 60 tablet, film coated in 1 bottle | 65862-036-60 | Aurobindo PharmaIndia | 5 May 2017 |
| 60 tablet in 1 bottle | 33342-003-09 | Macleods PharmaceuticalsIndia | 30 August 2018 |
| 500 tablet, film coated in 1 bottle | 76282-115-05 | Exelan Pharmaceuticals | 29 April 2015 |
| 60 tablet, film coated in 1 bottle | 76282-115-60 | Exelan Pharmaceuticals | 29 April 2015 |
| 60 tablet, film coated in 1 bottle | 72865-144-60 | XLCare Pharmaceuticals | 17 April 2020 |
| 6 tablet, film coated in 1 bottle | 71335-0639-1 | Bryant Ranch Prepack | 2 April 2021 |
| 60 tablet, film coated in 1 bottle | 71335-0639-2 | Bryant Ranch Prepack | 27 December 2021 |
| 4 tablet, film coated in 1 bottle | 71335-0639-3 | Bryant Ranch Prepack | 27 December 2021 |
| 6 tablet in 1 bottle | 71335-1916-1 | Bryant Ranch Prepack | 15 July 2021 |
| 60 tablet in 1 bottle | 71335-1916-2 | Bryant Ranch Prepack | 5 April 2024 |
| 4 tablet in 1 bottle | 71335-1916-3 | Bryant Ranch Prepack | 5 April 2024 |
| 6 tablet, film coated in 1 bottle, plastic | 43063-900-06 | PD-Rx Pharmaceuticals | 11 October 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lamivudine and Zidovudine 150 mg/300 mg tablet.
Clinical summary
Lamivudine and Zidovudine is a fixed-dose combination of a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor and a hepatitis B virus nucleoside analog reverse transcriptase inhibitor. It is available as tablets for oral use. MedsAcross supplies Lamivudine and Zidovudine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Lamivudine and ZidovudineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- COMBIVIR prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Combivir: European public assessment report (EPAR) · European Medicines Agency
Need Lamivudine and Zidovudine 150 mg/300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.